Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
Habtemariam S, Nabavi SF, Banach M, Berindan-Neagoe I, Sarkar K, Sil PC, Nabavi SM.
Habtemariam S, et al. Among authors: nabavi sm, nabavi sf.
Arch Med Res. 2020 Oct;51(7):733-735. doi: 10.1016/j.arcmed.2020.05.024. Epub 2020 May 31.
Arch Med Res. 2020.
PMID: 32536457
Free PMC article.